In tumors Salmonella migrate away from vasculature toward the transition zone and induce apoptosis
暂无分享,去创建一个
Sabha Ganai | Jeremy P. Sauer | Neil S. Forbes | Richard B. Arenas | N. Forbes | Brooke Bentley | S. Ganai | R. Arenas | B. Bentley | Brooke Bentley
[1] Nicholas Denko,et al. Overcoming Physiologic Barriers to Cancer Treatment by Molecularly Targeting the Tumor Microenvironment , 2006, Molecular Cancer Research.
[2] M. Sporn,et al. The tumour microenvironment as a target for chemoprevention , 2007, Nature Reviews Cancer.
[3] Rachel W. Kasinskas,et al. Salmonella typhimurium specifically chemotax and proliferate in heterogeneous tumor tissue in vitro , 2006, Biotechnology and bioengineering.
[4] X. Luo,et al. Tumor amplified protein expression therapy: Salmonella as a tumor-selective protein delivery vector. , 2001, Oncology research.
[5] John Mao,et al. Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] Meng Yang,et al. Targeted therapy with a Salmonella typhimurium leucine-arginine auxotroph cures orthotopic human breast tumors in nude mice. , 2006, Cancer research.
[7] Rachel W. Kasinskas,et al. Salmonella typhimurium lacking ribose chemoreceptors localize in tumor quiescence and induce apoptosis. , 2007, Cancer research.
[8] N. Forbes. Profile of a bacterial tumor killer , 2006, Nature Biotechnology.
[9] D. Hicklin,et al. Effect of p53 Status on Tumor Response to Antiangiogenic Therapy , 2002, Science.
[10] S. Rosenberg,et al. Continuous intravenous administration of live genetically modified salmonella typhimurium in patients with metastatic melanoma. , 2003, Journal of immunotherapy.
[11] N. Forbes,et al. Single‐cell analysis demonstrates how nutrient deprivation creates apoptotic and quiescent cell populations in tumor cylindroids , 2008, Biotechnology and bioengineering.
[12] M. Sznol,et al. Use of preferentially replicating bacteria for the treatment of cancer. , 2000, The Journal of clinical investigation.
[13] Qian Zhang,et al. Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins , 2004, Nature Biotechnology.
[14] Hyung-Seok Kim,et al. Inhibition of tumor growth and metastasis by a combination of Escherichia coli-mediated cytolytic therapy and radiotherapy. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.
[15] C. Lewis,et al. Bacterial delivery of a novel cytolysin to hypoxic areas of solid tumors , 2009, Gene Therapy.
[16] T M Cole,et al. A simple method for visualization of influential landmarks when using euclidean distance matrix analysis. , 1998, American journal of physical anthropology.
[17] R. Jain,et al. Can engineered bacteria help control cancer? , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[18] X. Luo,et al. Biodistribution and genetic stability of the novel antitumor agent VNP20009, a genetically modified strain of Salmonella typhimurium. , 2000, The Journal of infectious diseases.
[19] Mark W Dewhirst,et al. Intravascular location of breast cancer cells after spontaneous metastasis to the lung. , 2002, The American journal of pathology.
[20] I. Tannock,et al. Drug penetration in solid tumours , 2006, Nature Reviews Cancer.
[21] Samuel I. Miller,et al. Lipid A mutant Salmonella with suppressed virulence and TNFα induction retain tumor-targeting in vivo , 1999, Nature Biotechnology.
[22] Meng Yang,et al. Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[23] J. Pawelek,et al. Tumor-targeted Salmonella as a novel anticancer vector. , 1997, Cancer research.
[24] S. Rosenberg,et al. Antitumor Effects in Mice of the Intravenous Injection of Attenuated Salmonella Typhimurium , 2002, Journal of immunotherapy.
[25] David E. Housman,et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours , 1996, Nature.
[26] R. Rubin. The war on cancer. , 1996, U.S. news & world report.
[27] Paul J. Williams,et al. Actions of bisphosphonate on bone metastasis in animal models of breast carcinoma , 2000, Cancer.
[28] P. Vaupel,et al. Tumor hypoxia: causative factors, compensatory mechanisms, and cellular response. , 2004, The oncologist.
[29] A. Shiau,et al. Salmonella choleraesuis as an anticancer agent in a syngeneic model of orthotopic hepatocellular carcinoma , 2008, International journal of cancer.
[30] L. Chung,et al. Tumor microenvironment promotes cancer progression, metastasis, and therapeutic resistance. , 2007, Current problems in cancer.
[31] John Calvin Reed,et al. Inhibition of Tumor Growth Using Salmonella Expressing Fas Ligand , 2008, Journal of the National Cancer Institute.
[32] Dai Fukumura,et al. Sparse initial entrapment of systemically injected Salmonella typhimurium leads to heterogeneous accumulation within tumors. , 2003, Cancer research.
[33] N. Forbes,et al. Tumour-targeted delivery of TRAIL using Salmonella typhimurium enhances breast cancer survival in mice , 2009, British Journal of Cancer.
[34] Jochen Stritzker,et al. Tumor-specific colonization, tissue distribution, and gene induction by probiotic Escherichia coli Nissle 1917 in live mice. , 2007, International journal of medical microbiology : IJMM.